Technology News and Research

RSS

BaroFold licenses PreEMT Technology to Nuron Biotech for development of BaroFeron

BaroFold, Inc. today announced that it has entered into an agreement to exclusively license its PreEMT™ Technology to Nuron Biotech for the development of BaroFeron™ and follow-on interferon beta products. BaroFeron is a proprietary recombinant human interferon beta being developed for the treatment of multiple sclerosis. Specific terms of the agreement are not disclosed.

17 May 2010

Del Global Technologies files registration statement with SEC for rights offering

Del Global Technologies Corp. today announced that it filed a registration statement on Form S-1 with the Securities and Exchange Commission (the "SEC") for a rights offering to its existing shareholders. The rights offering will be made through the distribution of non-transferable subscription rights to purchase shares of the Company's common stock, par value $0.10 per share, at a subscription price to be determined.

17 May 2010

Aastrom Biosciences initiates treatment in Phase 2 catheter-based clinical trial for dilated cardiomyopathy

Aastrom Biosciences, Inc., the leading developer of autologous cellular therapies for the treatment of severe cardiovascular diseases, today announced that the first patient has been treated in the company's U.S. Phase 2 catheter-based clinical trial to treat dilated cardiomyopathy (DCM). Treatment was performed by interventional cardiologist Timothy D. Henry, M.D., FACC, at the Minneapolis Heart Institute® at Abbott Northwestern Hospital in Minneapolis, MN.

17 May 2010

Emisphere Technologies first-quarter net loss increases to $18.5 million

Emisphere Technologies, Inc. today announced its financial results for the first quarter 2010.

17 May 2010

Argos Therapeutics presents AGS-004 autologous dendritic cell therapy Phase 2a trial data at 19th CAHR

Argos Therapeutics today announced the presentation of data from the Phase 2a trial of AGS-004, demonstrating that the personalized immunotherapy has a positive impact on the genetic diversity of residual HIV virus, and also results in substantially increased time to viral rebound in HIV patients treated with AGS-004 following antiretroviral therapy (ART) interruption.

17 May 2010

Inovio Biomedical changes corporate name to Inovio Pharmaceuticals

Inovio Biomedical Corporation, a leader in the development of new preventive and therapeutic vaccines against cancers and infectious diseases, announced today that it has changed its corporate name to Inovio Pharmaceuticals, Inc. by filing a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of the State of Delaware on May 14, 2010. Inovio's trading symbol remains the same.

17 May 2010

Soligenix first-quarter revenues decrease to $336,000

Soligenix, Inc., a late-stage biopharmaceutical company, announced today its financial results for the first quarter of 2010.

17 May 2010

Providence Equity Partners to acquire Virtual Radiologic for $17.25 per share

Virtual Radiologic Corporation, a national radiology practice and a leader in the development of radiologist workflow technology, and Providence Equity Partners, a leading global private equity firm that manages over $22 billion in equity capital, today announced that they have entered into a definitive agreement under which Providence will acquire all of the outstanding common stock of vRad for $17.25 per share in cash.

17 May 2010

Freescale Semiconductor receives ZigBee Certification for wireless health and wellness solutions

Freescale Semiconductor today announced it has received ZigBee Certified product status for its ZigBee Health Care wireless health and wellness processing platforms. The ZigBee Certified products status is awarded to products that have been tested and met criteria for interoperability that enable wireless devices to securely and reliably monitor and manage noncritical, low-acuity health care services.

17 May 2010

Celldex Therapeutics commences screening in CDX-1307 Phase 2 study for bladder cancer

Celldex Therapeutics, Inc. today announced that the first patient has been screened in a randomized Phase 2 study of the Company's novel, first-in-class antibody-based vaccine candidate from its Precision Targeted Immunotherapy (PTI) platform. This study will evaluate the CDX-1307 regimen in both neoadjuvant and adjuvant settings in patients with newly diagnosed muscle-invasive bladder cancers that express hCG-beta.

17 May 2010

Biostar Pharmaceuticals first-quarter 2010 revenues increase 66.0% to $12.4 million

Biostar Pharmaceuticals, Inc., a Xianyang- based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsules, and a variety of pharmaceutical products, today announced financial results of the first quarter ended March 31, 2010.

17 May 2010

AngioDynamics launches Morpheus Smart PICC Triple Lumen CT PICC

AngioDynamics announced today the launch of the first member of its new generation of peripherally inserted central catheters (PICCs) for procedures involving the use of contrast media in computed tomography (CT) - the Morpheus Smart PICC Triple Lumen CT PICC.

17 May 2010

China Biologic first-quarter revenues up 28.1% to $27.1 million

China Biologic Products, Inc., one of the leading plasma-based biopharmaceutical companies in the People's Republic of China, operating through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co. Ltd. and Guiyang Dalin Biologic Technologies Co., Ltd. and its equity investment in Xi'an Huitian Blood Products Co., Ltd., today reported financial results for its first quarter ended March 31, 2010.

17 May 2010

University of Freiburg to host symposium on fate

The Institute of Medical Ethics and Medical History of the University of Freiburg is hosting the 1st Freiburg Symposium on the topic "The End of Fate? The Human Condition Between the Facts of Life and Medical-Technological Design."

17 May 2010

genOway and Griffith University sign research partnership and license for olfactory stem cells technology

genOway, the biotechnology company dedicated to the development of genetically modified animal models, today reports an agreement with the Griffith University (Brisbane, Australia) on a eight-months research partnership with its Eskitis Institute for Cell and Molecular Therapies focusing on autologous olfactory adult stem cells. This research program is coupled with a world wide exclusive license to genOway for the rodent transgenic business.

17 May 2010

Blood-flow fMRI to be used to study brain-wide impact of neural circuitry changes

Like a motorist who knows that the "check engine" light indicates something important but ill-defined is happening, neuroscientists have relied heavily on an incompletely understood technology called functional magnetic resonance imaging to show them what the brain is doing when people respond to different stimuli.

17 May 2010

UNC-developed technique has broad applications in cancer, biomedical research

A precise understanding of cellular growth and movement is the key to developing new treatments for cancer and other disorders caused by dysfunctional cell behavior. Recent breakthroughs in genetic medicine have uncovered how genes control whether cellular proteins are turned 'on' or 'off' at the molecular level, but much remains to be understood about how protein signaling influences cell behavior.

17 May 2010

Dartmouth College receives $35M to establish The Dartmouth Center for Health Care Delivery Science

Dartmouth College has received a $35 million commitment to establish The Dartmouth Center for Health Care Delivery Science, President Jim Yong Kim announced today. The anonymous gift will advance a new field of study, harnessing the knowledge and expertise of faculty across multiple disciplines from the arts and sciences as well as from the medical, business and engineering schools.

17 May 2010

Web seminar for hospitals considering central archive for MRIs, X-rays, CT scans, patient data

Iron Mountain Incorporated, the information management company, will hold a Web seminar May 18 for hospitals considering a central archive for MRIs, X-rays, CT scans and other patient data that is spread across separate technology systems.

15 May 2010

HHS announces $1 billion in Recovery Act awards for construction, repair and renovation of research facilities

U.S. Department of Health and Human Services Secretary Kathleen Sebelius today announced one billion dollars of American Recovery and Reinvestment Act funds have been awarded to construct, repair and renovate scientific research laboratories and related facilities across the country. The National Institutes of Health (NIH) National Center for Research Resources (NCRR) administered the grants, which are expected to create or sustain jobs nationwide and to help foster scientific advances that may lead to improved human health.

15 May 2010

Technology News and Research

BaroFold licenses PreEMT Technology to Nuron Biotech for development of BaroFeron

Del Global Technologies files registration statement with SEC for rights offering

Aastrom Biosciences initiates treatment in Phase 2 catheter-based clinical trial for dilated cardiomyopathy

Emisphere Technologies first-quarter net loss increases to $18.5 million

Argos Therapeutics presents AGS-004 autologous dendritic cell therapy Phase 2a trial data at 19th CAHR

Inovio Biomedical changes corporate name to Inovio Pharmaceuticals

Soligenix first-quarter revenues decrease to $336,000

Providence Equity Partners to acquire Virtual Radiologic for $17.25 per share

Freescale Semiconductor receives ZigBee Certification for wireless health and wellness solutions

Celldex Therapeutics commences screening in CDX-1307 Phase 2 study for bladder cancer

Biostar Pharmaceuticals first-quarter 2010 revenues increase 66.0% to $12.4 million

AngioDynamics launches Morpheus Smart PICC Triple Lumen CT PICC

China Biologic first-quarter revenues up 28.1% to $27.1 million

University of Freiburg to host symposium on fate

genOway and Griffith University sign research partnership and license for olfactory stem cells technology

Blood-flow fMRI to be used to study brain-wide impact of neural circuitry changes

UNC-developed technique has broad applications in cancer, biomedical research

Dartmouth College receives $35M to establish The Dartmouth Center for Health Care Delivery Science

Web seminar for hospitals considering central archive for MRIs, X-rays, CT scans, patient data

HHS announces $1 billion in Recovery Act awards for construction, repair and renovation of research facilities

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News